Insights
Using Solid Form Patents to Protect Pharmaceutical Products — Part II
A Genus-Species Approach for Claiming Pharmaceutical Salts Many drugs on the market today are formulated with active pharmaceutical ingredients in the form of salts rather than free acids or...
Read more
Using Solid Form Patents to Protect Pharmaceutical Products — Part I
Solid Form Patents as Drug Substance Patents In the pharmaceutical industry, it is well accepted that composition of matter patents are the most sought after and valuable patents for...
Read more
Moving in the Right Direction: Cocrystals and the FDA
Cocrystals as drug substance not drug product - new opportunities In 2013, FDA issued a final guidance called the "Regulatory Classification of Pharmaceutical Co-crystals." In that guidance,...
Read more
Solid Form Patents: Part I - Introduction and Laying the Genus/Species Foundation
Pharmaceutical products are typically dosed as solids, liquids (e.g., solutions) or gases. In gases and liquids, the molecules are tumbling; in solids, however, the molecules are essentially frozen...
Read more
Obviousness and Inherency in Solid Forms
Claimed inventions in issued patents must, of course, pass the statutorily required hurdles of novelty and non-obviousness. In the context of solid forms, there are particular nuances the...
Read more






